Correspondence

Outcomes in treatment with darunavir/ritonavir in ART-experienced paediatric patients

Bookmark and Share
Gurpreet Kindra, Nosisa Sipambo, Harry Moultrie, Lee Fairlie

Abstract


Increasing development of resistant mutations to first- and second-line antiretroviral (ART) regimens among chil- dren is a matter of concern, as limited third-line paediatric ART preparations are available in the public sector. 



Authors' affiliations

Gurpreet Kindra, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa

Nosisa Sipambo, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa; Chris Hani Baragwanath Hospital, Johannesburg, South Africa

Harry Moultrie, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa

Lee Fairlie, Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa; Chris Hani Baragwanath Hospital, Johannesburg, South Africa

Keywords

Darunavir, children, antiretroviral therapy, resistance, HIV

Cite this article

South African Medical Journal 2015;105(5):330-331. DOI:10.7196/SAMJ.9211

Article History

Date submitted: 2014-11-28
Date published: 2015-09-18

Article Views

Abstract views: 3658
Full text views:

Comments on this article

*Read our policy for posting comments here